NCT02590289View on ClinicalTrials.gov

A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Dermatitis, Atopic
Interventions
DRUG

BBI-5000

BBI-5000 low dose, middle dose, or high doses

Trial Locations (1)

68502

Celerion Inc., Lincoln

Sponsors
All Listed Sponsors
lead

Fresh Tracks Therapeutics, Inc.

INDUSTRY

NCT02590289 - A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter